雷氏品牌怎么样 申请店铺

我要投票 雷氏在珍珠粉行业中的票数:602 更新时间:2025-07-30
雷氏是哪个国家的品牌?「雷氏」是 上海雷允上药业有限公司 旗下著名品牌。该品牌发源于上海,由创始人苏俊英在1998-11-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷氏品牌出海!将品牌入驻外推网,定制雷氏品牌推广信息,可以显著提高雷氏产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

雷氏怎么样

百年老字号雷允上药店始建于苏州,发迹于上海,迄今已有近三百年历史。公元1734年(清雍正十二年)创始于苏州;1860年(清咸丰十年)设“申号”于上海新北门外,1934年设“北号”于河南北路天后宫桥(今河南路桥)北堍,1937年又设北号支店于静安寺路(今南京西路)。由于药店规模较大,资产雄厚,影响面广,早年就被国药同业公认为上海中药店“四大户"之一。中国改革开放以来,经资产重组,工商联手,今日上海雷允上药业雄风再现,成为中国中药行业的强者。雷允上药业历史渊源>>

上海雷允上药业有限公司是上药集团上海市药材有限公司为投资主体成立的集农工商、科工贸、产学研于一体的大型中药企业,历年被认定为上海市高新技术企业、上海市文明单位,是上海市第一批知识产权示范企业,旗下“雷氏”品牌被认定为中国驰名商标,并以20.8亿的品牌价值荣获中国500最具价值品牌称号。近年来,公司及其品牌先后获得中国百年中药老字号企业、最具价值的上海老商标、上海市出口名牌、上海市装备制造业与高新技术产业自主创新品牌、上海现代服务业百强等荣誉称号。

公司拥有严格的质量保证体系。从中药产业链源头GAP规范标准入手,严格原药材采购控制。拥有国家GMP规范要求的中药产业化制造基地,能生产20多个剂型500多个品种。拥有包括中药材、中成药、保健品和名贵参茸等在内的强大的专业营销网络,辐射全国,足迹遍及东南亚、北美、欧洲等地。雷允上连锁多年被评为最具影响力特许品牌。六神丸、雷氏珍菊降压片、雷氏炮天红酒等产品历年被评为上海市名牌产品,在海内外均享有较高的声誉。多年坚持开展社区健康服务,2006年赢得了“全国卫生进社区——相约健康社区行”社会公益奖。

公司传承“至诚至信,关爱生命”的企业追求,竭尽所能地致力于服务社会、造福人类的伟大事业,为弘扬祖国优秀中医药文化,为人类的健康贡献力量。

The century old drugstore under leiyunshang pharmaceutical was founded in Suzhou and started in Shanghai. It has a history of nearly 300 years. It was founded in Suzhou in 1734 (the 12th year of Yongzheng reign in the Qing Dynasty); in 1860 (the 10th year of Xianfeng reign in the Qing Dynasty), it was set up outside the new North Gate of Shanghai; in 1934, it was set up in the north end of hougongqiao (now Henan Road bridge), North Henan Road; in 1937, it was set up in Jingansi Road (now Nanjing West Road). Due to the large scale, strong assets and wide influence of drugstores, they have been recognized as one of the "four big families" of Shanghai Traditional Chinese medicine stores by the pharmaceutical industry in the early years. Since China's reform and opening up, through asset restructuring and joint efforts of industry and commerce, the pharmaceutical industry of Shanghai leiyunshang Pharmaceutical Co., Ltd. has reappeared today, becoming a strong player in the Chinese traditional medicine industry. The history of pharmaceutical industry under leiyunshang pharmaceutical & gt; & gt; Shanghai leiyunshang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise established by Shanghai Pharmaceutical Group Co., Ltd. as the main investor, integrating agriculture, industry and commerce, science, industry and trade, production, learning and research. It has been recognized as a high-tech enterprise in Shanghai and a civilized unit in Shanghai. It is the first batch of intellectual property demonstration enterprises in Shanghai. Its "Leishi" brand is recognized as a well-known trademark in China Won the title of China's 500 most valuable brand with a brand value of 2.08 billion. In recent years, the company and its brand have successively won the honorary titles of China's century old brand enterprise of traditional Chinese medicine, the most valuable old trademark of Shanghai, Shanghai Export famous brand, independent innovation brand of Shanghai equipment manufacturing industry and high-tech industry, and top 100 modern service industry of Shanghai. The company has a strict quality assurance system. Starting from the gap standard of the source of traditional Chinese medicine industry chain, strictly control the purchase of original Chinese medicine. It has the industrialization manufacturing base of traditional Chinese medicine required by the national GMP standard, and can produce more than 20 dosage forms and more than 500 varieties. It has a strong professional marketing network including traditional Chinese medicine, Chinese patent medicine, health care products and rare ginseng antler, covering the whole country, covering Southeast Asia, North America, Europe and other places. Leiyunshang chain has been rated as the most influential franchise brand for many years. Liushenwan, Zhenju hypotensive tablet and Baotian red wine have been rated as famous brand products in Shanghai over the years, enjoying a high reputation at home and abroad. In 2006, it won the social public welfare award of "national health into the community - meeting healthy communities". The company inherits the enterprise pursuit of "sincere and trustworthy, caring for life", devotes itself to the great cause of serving the society and benefiting the human as much as possible, promotes the excellent traditional Chinese medicine culture of the motherland and contributes to the health of human beings.

本文链接: https://brand.waitui.com/942bfee42.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

理想汽车-W获南向资金净买入20.93亿港元

南向资金今日净买入117.14亿港元。其中理想汽车-W、石药集团、美团-W净买入额位列前三,分别获净买入20.93亿港元、8.73亿港元、4.47亿港元。净卖出方面,中芯国际、信达生物、国泰君安国际分别遭净卖出2.05亿港元、1.21亿港元、0.74亿港元。(第一财经)

2小时前

“致知博约”完成数千万元Pre-A轮融资

36氪获悉,半导体封装材料企业“致知博约”近日完成数千万元Pre-A轮融资,由险峰长青、鼎兴量子、国汽投资、成都倍特及海河清韦五家机构联合注资。本轮资金将用于华南、长三角及四川三地生产基地建设,同步扩充研发团队并引入半导体封装检测设备。

2小时前

美丽生态:二季度新签订单金额合计3.48亿元

36氪获悉,美丽生态发布公告,公司2025年第二季度新签订单14个,金额合计3.48亿元。

2小时前

金河生物:上半年净利润1.38亿元,同比增51.52%

36氪获悉,金河生物披露半年度报告,公司2025年上半年实现营业收入为13.9亿元,同比增长30.45%;归属于上市公司股东的净利润1.38亿元,同比增长51.52%;基本每股收益0.18元。

2小时前

印度据悉仍致力于秋季之前与美国达成双边贸易协议

知情人士称,尽管美国总统唐纳德·特朗普推进威胁实施的关税,印度官员仍计划继续在今年秋季之前与美方磋商双边贸易协议。内部计算显示,如果对印度征收超过25%的关税,7月至9月期间约有10%的出口将受到影响。该知情人士表示,电子产品、宝石和珠宝等行业都将受到影响。(财联社)

2小时前

本页详细列出关于雷氏的品牌信息,含品牌所属公司介绍,雷氏所处行业的品牌地位及优势。
咨询